Hawaii recently fined Bristol Myers Squibb and Sanofi under consumer protection standards for their drug Plavix (clopidogrel). This could be a game changing case due to the fact that it could have been prevented with more studies using pharmacogenomics.
Becky Winslow, of PGX for Pharmacists podcast, joins me in this hybrid episode where we discuss not only the Plavix case but several other cases where pharmacogenomics could help make a huge difference in our healthcare system, including in how we treat opioid addiction.
https://podcasts.apple.com/us/podcast/pgx-for-pharmacists/id1496611877
view more